Ernährungswissenschaftlerin

Profilbild von Prof. Dr. biol.hum. Marion Flechtner-Mors

Prof. Dr. biol.hum. Marion Flechtner-Mors

Ernährungswissenschaftlerin

   

  • 1990 Diplom Universität Hohenheim
  • 1995 Promotion Universität Ulm
  • 2005 Habilitation Universität Hohenheim
  • 2009 Umhabilitation Universität Ulm
  • Dez. 2016 Ernennung zum apl. Prof.
  • Streicher M, van Zwienen-Pot J, Bardon L, Nagel G, Teh R, Meisinger C, Colombo M, Torbahn G, Kiesswetter E, Flechtner-Mors M, Denkinger M, Rothenbacher D, Thorand B, Ladwig KH, Corish CA, Clarke M, Kerse N, Muru-Lanning M, Gibney ER, O'Connor EM, Visser M, Volkert D; MaNuEL consortium. Determinants of Incident Malnutrition in Community-Dwelling Older Adults: A MaNuEL Multicohort Meta-Analysis. J Am Geriatr Soc. 2018 Aug 23. doi: 10.1111/jgs.15553. [Epub ahead of print]

  • Brug J, van der Ploeg HP, Loyen A, Ahrens W, Allais O, Andersen LF, Cardon G, Capranica L, Chastin S, De Bourdeaudhuij I, De Craemer M, Donnelly A, Ekelund U, Finglas P, Flechtner-Mors M, Hebestreit A, Kubiak T, Lanza M, Lien N, MacDonncha C, Mazzocchi M, Monsivais P, Murphy M, Nicolaou M, Nöthlings U, O'Gorman DJ, Renner B, Roos G, van den Berg M, Schulze MB, Steinacker JM, Stronks K, Volkert D, Lakerveld J; DEDIPAC consortium. Determinants of diet and physical activity (DEDIPAC): a summary of findings. Int J Behav Nutr Phys Act. 2017 Nov 3;14(1):150. doi: 10.1186/s12966-017-0609-5.

  • Schumann U, Jenkinson CP, Alt A, Zügel M, Steinacker JM, Flechtner-Mors M. Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects. PLoS One. 2017 Mar 27;12(3):e0173803. doi: 10.1371/journal.pone.0173803. eCollection 2017.

  • He CW, Parowatkin M, Mailänder V, Flechtner-Mors M, Ziener U, Landfester K, Crespy D. Sequence-Controlled Delivery of Peptides from Hierarchically Structured Nanomaterials. ACS Appl Mater Interfaces. 2017 Feb 1;9(4):3885-3894. doi: 10.1021/acsami.6b13176. Epub 2017 Jan 17.

  • He W, Parowatkin M, Mailänder V, Flechtner-Mors M, Graf R, Best A, Koynov K, Mohr K, Ziener U, Landfester K, Crepy D. Nanocarrier for oral peptide delivery produced by polyelectrolyte complexation in nanoconfinement. Biomacromolecules 2015;16(8):2282-7
  • Flechtner-Mors M, Schwab KO, Fröhlich-Reiterer EE, Kapellen TM, Meissner T, Rosenbauer J, Stachow R, Holl RW. Overweight and obesity based on four reference systems in 18382 paediatric patients with type 1 diabetes from Germany and Austria. J Diabetes Res 2015;2015:370753
  • Flechtner-Mors M, Neuhauser H, Reinehr T, Roost HP, Wiegand S, Siegfreid W, Zwiauer K, Molz E, Holl RW for the APV initiative and the BMBF Competence Network Obesity. Blood pressure in 57931 overweight or obese paediatric patients based on five reference systems. Am J Cardiol, 2015;115(11):1587-94
  • Böttcher C, Dost A, Wudy SA, Flechtner-Mors M, Borkenstein M, Schiel R, Weitzel D, Bechtold-Dalla Pozza S, Wolf J, Holl RW, for the German/Austrian Diabetes Prospective Documentation Initiative. Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycaemia rate in children and adolescents with type 1 diabetes. Diabetes Technol Ther 2015; 17(4):275-82
  • Lakerveld J, van der Ploeg HP, Kroeze W, Ahrens W, Allais O, Frost Andersen L, Cardon G, Capranica L, Chastin S, Donnelly A, Ekelund U, Finglas P, Flechtner-Mors M et al. Towards the integration and development of a cross-European research network and infrastructure: The Determinants of Diet and Physical Activity (DEDIPAC) knowledge hub. IJBNPA 2014, 11: 143
  • Hubel JM, Schmidt SA, Mason RA, Haenle MM, Oeztuerk S, Koenig W, Boehm BO, Kratzer W, Graeter, Flechtner-Mors M; the EMIL-Study Group Influence of plasma cortisol and other laboratory parameters on non-alcoholic fatty liver disease. HMR 2014; 46(4):287-93
  • Flechtner-Mors M, George SN, Oeztuerk S, Haenle MM, Koenig W, Imhof A, Boehm BO, Graeter T, Mason RA, Kratzer W, Akinli AS. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample. BMC Research Notes 7:207, 2014
  • Kapellen TM, Gausche R, Dost A, Wiegand S, Flechtner-Mors M, Keller E, Kiess W, Holl RW; DPV-Science-Initiative of the German Competence Network Diabetes and the German Competence Network Obesity (Consortium LARGE). Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database. J Pediatr Endocrinol Metab 1:27(3-4):209-14, 2014
  • Meissner T, Wolf J, Kersting M, Fröhlich-Reiterer E, Flechtner-Mors M, Salgin B, Stahl-Pehe A, Holl RW. Carbohydrate intake in relation to BMI, HbA1c and lipid profile in children and adolescents with type 1 diabetes. Clin Nutr. 33(1).75-8, 2014
  • Flechtner-Mors M, Schick A, Oeztuerk S, Haenle MM, Wilhelm M, Koenig W, Imhof A, Boehm BO, Graeter T, Mason RA, Kratzer W, Akinli AS and the EMIL-Study group. Associations of fatty liver disease and other factors affecting serum SHBG concentrations – a population based study on 1657 subjects. HMR 2014; 46(4):287-93
  • Bächle C, Icks A, Straßburger K, Flechtner-Mors M, Hungele A, Beyer P, Placzek K, Hermann U, Schumacher A, Freff M, Stahl-Pehe A, Holl RW, Rosenbauer J on behalf of the DPV Initiative and the German BMBF Competence Network Diabetes Mellitus. Direct diabetes-related costs in young patients with early-onset, long-lasting type 1 diabetes. PLoS One 13;8(8):e70567, 2013
  • Flechtner-Mors M,  Wiegand S, Gellhaus I, Siefken-Kaletka H, Widhalm K, Reinehr T, Roost HP, Leipold G, Hoffmeister U, Holl RW. Screening for co-morbidity in 65397  pediatric patients from Germany, Austria and Switzerland. Adherence to Guidelines improved from the year 2000 to 2010.  Obes Facts. 6(4):360-8, 2013
  • Flechtner-Mors M, Thamm M, Wiegand S, Reinehr T, Schwab K.O, Kiess W, Widhalm K, Holl RW for the APV initiative and the BMBF Competence Network Obesity. Comorbidities related to BMI category in children and adolescents: German/Austrian/Swiss obesity register APV compared to the German KiGGS study. Horm Res Paediatr 77(1):19-26, 2012
  • Flechtner-Mors M, Thamm M, Rosario AS, Goldapp C, Hoffmeister U, Mann R, Bullinger M, van Egmond-Fröhlich A, Ravens-Sieberer U, Reinehr T, Westenhöfer J, Holl RW. Cardiovascular Risk Factors in Overweight or Obese Children and Adolescents: Data of the BZgA-Observational Study (EvAKuJ-Project) in Klin Padiatr (Article in German). Klin Padiatr 223(7):445-449, 2011  German  
  • Holl RW, Hoffmeister U, Thamm M, Stachow R, Keller KM, L’Allemand D, Widhalm K, Flechtner-Mors M, Wiegand S. Does obesity lead to a specific lipid disorder ? Analysis from the German/Austria/Swiss APV registry. Int J Pediatr Obes 6Supp1:53-8, 2011
  • Flechtner-Mors M, Boehm BO, Wittman R, Thoma U, Ditschuneit HH. Enhanced weight loss with protein-enriched meal replacements in subjects with the metabolic syndrome. Diab Metab Res Rev. 26(5):393-405, 2010  
  • Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH. Metabolism in adipose tissue in response to citalopram and trimipramine treatment – An in situ microdialysis study. J Psychiat Res 42:578-586, 2008
  • Jenkinson CP, Coletta DK, Flechtner-Mors M, Hu SL, Fourcaudot MJ, Rodriguez LM, Schneider J, Arya R, Stern MP, Blangero J, Duggirala R, Defronzo RA. Association of Genetic Variation in ENPP1 With Obesity-related Phenotypes. Obesity 16(7):1708-1713, 2008
  • Flechtner-Mors M, Jenkinson CP, Alt A, Biesalski HK, Adler G, Ditschuneit HH. Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique. J Physiol Pharmacol 56(3):355-368, 2005        
  • Flechtner-Mors M, Biesalski HK, Jenkinson CP, Adler G, Ditschuneit HH. The effects of moderate consumption of white wine on weight loss in overweight and obese subjects. Int J Obes 28:1420-1426, 2004            
  • Flechtner-Mors M, Jenkinson CP, Alt A, Biesalski HK, Adler G, Ditschuneit HH. Sympathetic regulation of glucose uptake by the 1-adrenoceptor in human obesity. Obes Res 12(4):612-620, 2004                    
  • Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH. In vivo 1-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. J Pharmacol Exp Ther 301:229-233, 2002                    
  • Ditschuneit HH, Frier HI, Flechtner-Mors M. Lipoprotein responses to weight loss and weight maintenance in high-risk obese subjects. Eur J Clin Nutr 56(3):264-70, 2002                                
  • Ditschuneit HH, Flechtner-Mors M. Value of structured meals for weight management: risk factors and long-term weight maintenance. Obes Res 9 Suppl 5:S284-9, 2001        
  • Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH. Effects of acipimox in subcutaneous adipose tissue of obese subjects. Diabetes-Metab Res 17(5):387-390, 2001                            
  • Flechtner-Mors M, Jenkinson CP, Alt A, Adler G, Ditschuneit HH. Norepinephrine induced glycerol release from adipose tissue: influence of age and body mass index in obese people. Nutrition 17:729-731, 2001    
  • Flechtner-Mors M, Ditschuneit HH, Johnson TD, Suchard MA, Adler G. Metabolic and weight loss effects of long-term dietary intervention in obese patients. Four-year results. Obes Res 8:399-402, 2000        
  • Flechtner-Mors M, Ditschuneit HH, Jenkinson CP, Alt A, Adler G.  Metformin inhibits catecholamine stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study. Diab Med 16:1000-1006, 1999                    
  • Flechtner-Mors M, Ditschuneit HH, Yip I, Adler G. Sympathetic modulation of lipolysis in subcutaneous adipose tissue: effects of gender and energy restriction. J Lab Clin Med 134(1):33-41, 1999                
  • Flechtner-Mors M, Ditschuneit HH, Yip I, Alt A, Torres-Schow RM, Membrano S, Caquin R, Tam C, Johnson T, Heber D. Reduced epinephrine-stimulated lipolytic activities in male golden-mantled ground squirrel during hibernation: an in situ microdialysis study. Comp Biochem Physiol B Biochem Mol Biol 123(3):281-4, 1999                                
  • Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. AJCN 69(2):198-204, 1999        
  • Flechtner-Mors M, Ditschuneit HH, Yip I, Adler G. Blood pressure and plasma norepinephrine responses to dexfenfluramine in obese post-menopausal women. AJCN 67:611-615, 1998    
  • Ditschuneit HH, Flechtner-Mors M, Adler G. The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity. J Card Risc 3:397-403, 1996            
  • Ditschuneit HH, Flechtner-Mors M, Adler G. The effect of withdrawal and re-introduction of dexfenfluramine in the treatment of obesity. Int J Obes 20:280-282, 1996            
  • Ditschuneit HH, Flechtner-Mors M, Adler G. Lipoprotein(a) in obesity before and after weight reduction. NMCD 6:32-38, 1996                
  • Ditschuneit HH, Flechtner-Mors M, Adler G. Fibrinogen in obesity before and after weight reduction. Obes Res 3:43-48, 1995            
  • Ditschuneit HH, Knispel D, Flechtner-Mors M, Voisard R, Ditschuneit H. The effects of an oral fat load on serum lipoproteins in obesity. NMCD 4:20-27, 1994
  • Ditschuneit HH, Flechtner-Mors M, Dolderer D, Fulda U, Ditschuneit H. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity. HMR 25:573-578, 1993                        
  • Ditschuneit HH, Flechtner-Mors M, Hagel E, Ditschuneit H. Postprandial lipoprotein metabolism in obese patients with moderate hypertriglyceridemia. J Int Med Res 20:197-210, 1992                    
  • Ditschuneit HH, Knispel D, Flechtner-Mors M, Voisard R, Ditschuneit H. Postprandial lipemia in coronary artery disease: Effects of Acipimox. Coronary Artery Disease 3:49-56, 1992

            

Buchbeiträge
  • Flechtner-Mors M. Continuing Medical Education. Portion Controlled Diets. 2003. In: Progress in Obesity Research: 9. Medeiros-Neto G, Halpern A, Bouchard C (eds.). John Libbey, UK, pp.1018-1021
Artikel
  • Flechtner-Mors M. Efficacy of meal replacements for weight management. Вопросы диетологии, 2013, т. 3, №4, с.1-4
  • Flechtner-Mors M. Mahlzeitenersatzstrategie mit Formulaprodukten zur Therapie der Adipositas. Adipositas 4:184-189, 2009
  • Flechtner-Mors M. Milch und Übergewicht. Ärztemagazin Phoenix. 2009
  • Flechtner-Mors. Proteinreiche Kost zur Gewichtsreduktion.  In: richtig essen - gesünder
  • leben. Aktuelles aus Wissenschaft und Praxis, www. cma.de/content/ernaehrungs-wissen/ernährungsinformationen-aktuell.php, Ausgabe 03/2007
  • Flechtner-Mors M. Molke: Protein und Calcium = Gewichtsabnahme. Ärztemagazin Phoenix. 3/2007, S. 12-13
  • Flechtner-Mors M. Molke in der Adipositastherapie. Die Medizinische Welt 4:153-157, 2006
  • Flechtner-Mors M. Proteinreiche Kost zur Gewichtsreduktion. Ärztemagazin Phoenix. Ausgabe 1/2006, S. 4-5
  • Flechtner-Mors M. Bedeutung von Protein in der Adipositastherapie. Ernährung im Fokus 12:326-331, 2004